Antibiotic therapy and Umbilical erythema

Summary:

Umbilical erythema is found among people with Antibiotic therapy, especially for people who are female, 0-1 old.

The study analyzes which people have Umbilical erythema with Antibiotic therapy. It is created by eHealthMe based on reports of 21 people who have Antibiotic therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 30, 2023

21 people who have Antibiotic Therapy and Umbilical Erythema are studied.


What is Antibiotic therapy?

Antibiotic therapy is found to be associated with 280 drugs and 109 conditions by eHealthMe.

What is Umbilical erythema?

Umbilical erythema (redness at umbilical site) is found to be associated with 88 drugs and 85 conditions by eHealthMe.

Number of Umbilical erythema in Antibiotic therapy reports submitted per year:

Would you have Umbilical erythema when you have Antibiotic therapy?

Gender of people who have Antibiotic Therapy and experienced Umbilical Erythema *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Antibiotic Therapy and experienced Umbilical Erythema *:

  • 0-1: 100 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Respiratory Tract Infection: 21 people, 100.00%
  2. Stenotrophomonas Infection: 20 people, 95.24%
  3. Acute Kidney Failure: 15 people, 71.43%

Common drugs taken by these people *:

  1. Cefotaxime: 14 people, 66.67%
  2. Vancomycin: 11 people, 52.38%
  3. Cefotaxime Sodium: 7 people, 33.33%
  4. Vancomycin Hcl: 5 people, 23.81%
  5. Meropenem: 2 people, 9.52%
  6. Levofloxacin: 2 people, 9.52%
  7. Erythromycin: 2 people, 9.52%
  8. Diprosone: 2 people, 9.52%
  9. Amoxicillin: 2 people, 9.52%
  10. Vancomycin Hydrochloride: 1 person, 4.76%

Common symptoms for these people *:

  1. Premature Baby: 21 people, 100.00%
  2. Stenotrophomonas Infection: 21 people, 100.00%
  3. Fatigue (feeling of tiredness): 21 people, 100.00%
  4. Pneumonia Bacterial (pneumonia associated with bacterial infection): 21 people, 100.00%
  5. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 18 people, 85.71%
  6. Hypotonia (low muscle tone): 17 people, 80.95%
  7. Acute Kidney Failure: 17 people, 80.95%
  8. Respiratory Disorder (respiratory disease): 17 people, 80.95%
  9. Sepsis (a severe blood infection that can lead to organ failure and death): 17 people, 80.95%
  10. Pneumonia: 12 people, 57.14%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Umbilical erythema?

Check whether Umbilical erythema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Umbilical erythema:

All the drugs that are associated with Umbilical erythema:

All the conditions that are associated with Umbilical erythema:

How the study uses the data?

The study is based on Umbilical erythema and Antibiotic therapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: